Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Biotechnol. 2008 Dec;26(12):653-8. doi: 10.1016/j.tibtech.2008.08.004. Epub 2008 Oct 30.

The challenges of regulating stem cell-based products.

Author information

  • 1College of Law, University of Saskatchewan, 15 Campus Drive, Saskatoon, SK S7N 5A6, Canada. barbara.vontigerstrom@usask.ca

Abstract

Appropriate regulation of stem cell-based products is essential to ensure public safety and trust while minimising unnecessary barriers to product development, but presents numerous challenges. Weaknesses of existing legal frameworks include variation between jurisdictions and poor fit between product categories and new technologies. The new European Regulation on advanced therapy medicinal products is an important attempt to provide a consolidated regulatory framework for novel products. Others can learn from issues encountered in its development, including definition of product categories, ethical concerns, and the application of regulations to small-scale production. Several aspects of the Regulation will be useful models, but some larger questions remain unresolved. As reform efforts move forward, harmonisation and sharing of expertise will be vital to effective regulation.

PMID:
18977047
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk